← Portfolio Scout

Portfolio company

Nanopath

United States · £7.9m raised

Raised

£7.9m

Latest stage

Series A

Rounds recorded

1

Backed by

5 investors

Sectors

Deep TechDigital Health

About

This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.

Source

Funding history · 1

Similar companies